Who founded elevatebio?

elevatebio was founded by David Hallal.

Who are elevatebio's investors?

elevatebio's investors include EcoR1 Capital, MPM BioImpact, Samsara BioCapital, SoftBank Vision Fund.

Where is elevatebio headquartered?

elevatebio is headquartered in Waltham, US.

elevatebio

Waltham, US · 447 employees on LinkedIn · 4 known investors

Find your way into elevatebio

94 people in our graph share verified history with the elevatebio team — schools, employers, funds. One of them is your warm intro.

Jefte Drijversunlockedknows Ger Brophy · together at elevatebio

knows the team · via elevatebio

×9knows the team · via Dublin City University

knows the team · via Altaris, LLC

ElevateBio is a contract development and manufacturing organization (CDMO) for advanced therapies, offering discovery, process development, analytics, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA therapeutics, and gene editing. It partners with drug developers to bring cell and gene therapies from early discovery through commercial-scale cGMP manufacturing.

Biotech Deep Tech Healthtech

Founders & leadership

David HallalinCEO

Mike PagliaChief Technology Officer

Ger Brophy inCEOGer Brophy led the BioPharma Production division at Avantor prior to its $3B+ IPO in 2019 and brings life sciences industry experience with board involvement in technology companies.

Investors · 4

EcoR1 CapitalSan Francisco

MPM BioImpactBoston · $1M – $15M

Samsara BioCapitalPalo Alto

SoftBank Vision FundLondon

Competitors · 1

by search overlap

AskBio42 shared keywordsAskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease. It operates as a wholly owned, independent subsidiary of Bayer AG.

Companies competing with elevatebio for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does elevatebio do?: ElevateBio is a contract development and manufacturing organization (CDMO) for advanced therapies, offering discovery, process development, analytics, manufacturing, and regulatory support for cell therapies, viral vectors, mRNA therapeutics, and gene editing. It partners with drug developers to bring cell and gene therapies from early discovery through commercial-scale cGMP manufacturing.
Who founded elevatebio?: elevatebio was founded by David Hallal.
Who are elevatebio's investors?: elevatebio's investors include EcoR1 Capital, MPM BioImpact, Samsara BioCapital, SoftBank Vision Fund.
Where is elevatebio headquartered?: elevatebio is headquartered in Waltham, US.